16 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
GeoVax Labs, Inc. (NASDAQ: GOVX) rose 29.7% to $5.42 in pre-market trading after the company reported the purchase of exclusive rights to PNP Therapeutics' development and commercialization of Gedeptin.